Ryman Healthcare Ltd
NZX:RYM
Ryman Healthcare Ltd
NZX:RYM
Price:
2.25
NZD
-0.88%
Market Cap:
NZ$2.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Ryman Healthcare Ltd
NZX:RYM
|
NZ |
|
N
|
NIO Inc
SWB:N3IA
|
CN |
|
Telefonica SA
MAD:TEF
|
ES |
|
M
|
Mitie Group PLC
OTC:MITFF
|
UK |
|
Vipshop Holdings Ltd
NYSE:VIPS
|
CN |
|
D
|
DND PharmaTech Inc
KOSDAQ:347850
|
KR |
|
E
|
Ebebek Magazacilik AS
IST:EBEBK.E
|
TR |
|
Principal Financial Group Inc
NASDAQ:PFG
|
US |
Wall St Price Targets
RYM Price Targets Summary
Ryman Healthcare Ltd
Ryman Healthcare Ltd
Wall Street analysts forecast RYM stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for RYM is 3.01 NZD with a low forecast of 2.59 NZD and a high forecast of 3.68 NZD.
Lowest Forecast
Price Target
2.59
NZD
15% Upside
Average Forecast
Price Target
3.01
NZD
34% Upside
Highest Forecast
Price Target
3.68
NZD
63% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RYM's stock price target?
Price Target
3.01
NZD
3.01
NZD
According to Wall Street analysts, the average 1-year price target for RYM is 3.01 NZD with a low forecast of 2.59 NZD and a high forecast of 3.68 NZD.
What is the Revenue forecast for Ryman Healthcare Ltd?
Projected CAGR
9%
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 3 years is 9%.
